trial · primary record
5-Aminolevulinic Acid Hydrochloride Powder for Oral Solution
5-aminolevulinic Acid
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 79 |
| Primary completion | 2027-12 |
| Primary endpoint | Positive Predictive Value |
| Registry ID | NCT06160492 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:50.435Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06160492
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.